Novartis Cosentyx’s first IL-17 inhibitor to receive EU approval
Cosentyx is the only biologic that can be used as first-line systemic therapy in the treatment of psoriasis and as an alternative…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.